Clinical perspectives of emerging pathogens in bleeding disorders.
about
Threat of dengue to blood safety in dengue-endemic countriesThe safety of pharmacologic options for the treatment of persons with hemophilia.Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in ItalyConsensus review of the treatment of cardiovascular disease in people with hemophilia A and B.Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors.Diagnostic approach to inherited bleeding disorders.Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.Current options and new developments in the treatment of haemophilia.Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate.Innovative approach for improved rFVIII concentrate.Malaria and blood transfusion: major issues of blood safety in malaria-endemic countries and strategies for mitigating the risk of Plasmodium parasites.Coagulation Factor IX for Hemophilia B Therapy.Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice.Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter?Managing haemophilia for life: 4th Haemophilia Global Summit.Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance?Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications.Assessing the costs and benefits of perioperative iron deficiency anemia management with ferric carboxymaltose in Germany.
P2860
Q22305635-D9A56DBD-694C-4AE4-BF5F-09FE4F4781ABQ30249200-BF3054A1-3C6D-4401-BCBA-FD2C7FABF03CQ34416394-98DB4AF4-1BB0-4377-834A-7B110F33C297Q35069871-33282121-66B1-4768-92FC-402B683FB32CQ36019034-4634B994-F9E9-4167-B75E-FE237F3141DBQ36715734-9FAA8FC3-78E0-4088-9CBE-91348D3CD9FBQ37234113-E90FBECB-597D-4C04-9A71-7446A0CC7BCBQ37841547-51A3E48B-8C90-4BD9-B747-9C5323C5A37CQ38115586-390FA256-E96B-45BF-9DCA-21C42E28F00BQ38207134-0AD88CC6-2755-44D6-8F88-A722A88921ECQ38623914-4A239C3D-CF60-4BE9-9A8D-3BB1E1278212Q42256024-407FD209-441F-4B6F-99A0-35A3B7A895BDQ42958772-903E0BB1-C948-46A3-B5F6-D0AE2E5B7665Q43146818-FC5553E9-2344-4592-ADD5-FA75983DC3A2Q44122887-DA92B38F-03E1-4623-9D33-12373EDA1C67Q45869919-3A7130C0-689A-4273-846B-BA7397BA3210Q51135382-7F0EE761-1B01-41CC-9CDC-218CA8682545Q55485778-17A557EF-1E1C-4EAF-9A04-C22D80EF0E42
P2860
Clinical perspectives of emerging pathogens in bleeding disorders.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Clinical perspectives of emerging pathogens in bleeding disorders.
@ast
Clinical perspectives of emerging pathogens in bleeding disorders.
@en
type
label
Clinical perspectives of emerging pathogens in bleeding disorders.
@ast
Clinical perspectives of emerging pathogens in bleeding disorders.
@en
prefLabel
Clinical perspectives of emerging pathogens in bleeding disorders.
@ast
Clinical perspectives of emerging pathogens in bleeding disorders.
@en
P2093
P1433
P1476
Clinical perspectives of emerging pathogens in bleeding disorders
@en
P2093
Bruce Ritchie
Christopher A Ludlam
Jamie Siegel
Mario von Depka
Marion A Koerper
Michael Diamond
Michael L Tapper
Roshni Kulkarni
Samuel Bozzette
Samuel Stanley
P304
P356
10.1016/S0140-6736(06)68036-7
P407
P577
2006-01-01T00:00:00Z